Patent Assignment
Reel/Frame 026125/0383
Assignment of Assignor's Interest
Recorded: 2011-04-14
Pages: 3
Assignors
GENEVOIS-BORELLA, ARIELLE
Executed: 2003-05-20
CAPET, MARC
Executed: 2003-06-12
CHEVE, MICHEL
Executed: 2003-05-20
Assignee
AVENTIS PHARMA S.A.
20 AVENUE RAYMOND ARON, ANTONY, 92160, FRANCE
Covered Property
(1)
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 14, 2011
From: AVENTIS PHARMA S.A.
To: TARGACEPT, INC.
Reel/Frame 026125/0389 →
Assignment of Assignor's Interest
Apr 14, 2011
From: SCHMITT, JEFFREY DANIEL; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 026125/0386 →
Change of Name
Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Assignment of Assignor's Interest
Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Patent Security Agreement
Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment.
Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →